Emerging Biomarkers for Early Detection of Bladder Cancer
European Journal of Clinical Pharmacy · 22.12.2025 · 7 (1) · 6150-6155
DOI: 10.61336/ejcp/25-12-282 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 22.12.2025. Verfasst von Muhammad Shahid Bhatti.
Abstract (Originalsprache)
Early detection of bladder cancer remains challenging due to the limitations of conventional diagnostic modalities such as cystoscopy and urine cytology. Emerging urinary and serum biomarkers have shown potential for improving non-invasive detection and risk stratification.
Objective
To evaluate the diagnostic performance of selected emerging biomarkers for early detection of bladder cancer and to assess their association with tumor grade and invasiveness.
Methods
This was a hospital-based cross-sectional analytical study conducted at Pir Abdul Qadir Shah Institute of Medical Sciences, Gambat from May 2024 to May 2025 including 125 adult patients with clinically suspected or newly diagnosed bladder lesions.
Results
Malignancy was confirmed in 78 patients (62.4%). Urinary NMP22 (28.6 ± 9.4 U/mL vs 11.2 ± 4.8 U/mL), BTA (41.5 ± 13.1 U/mL vs 18.7 ± 6.5 U/mL), miR-21 expression (3.8 ± 1.2 vs 1.4 ± 0.6), DNA methylation score (0.72 ± 0.14 vs 0.38 ± 0.10), and serum ctDNA (24.9 ± 7.6 ng/mL vs 9.5 ± 3.7 ng/mL) were significantly elevated in malignant cases (p
Zitieren
APA
Bhatti, M. S. (2025). Emerging Biomarkers for Early Detection of Bladder Cancer. European Journal of Clinical Pharmacy, 7(1), 6150-6155. https://doi.org/10.61336/ejcp/25-12-282
Vancouver
Bhatti MS. Emerging Biomarkers for Early Detection of Bladder Cancer. European Journal of Clinical Pharmacy. 2025;7(1):6150-6155. doi:10.61336/ejcp/25-12-282
BibTeX
@article{Bhatti2025,
author = {Bhatti, Muhammad Shahid},
title = {Emerging Biomarkers for Early Detection of Bladder Cancer},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {6150--6155},
doi = {10.61336/ejcp/25-12-282}
}
EUVIMED